Vyndamax 61 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FDD2J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,593
Award facts
- Contract value 100% obligated
- $14,592.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,592.57 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) on February 3, 2026, with completion scheduled for February 25, 2026. This non-set-aside, firm fixed-price award was issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and subsidiary of parent company Cencora, Inc., and was competitively selected to fulfill this specific pharmaceutical requirement.
Vyndamax is a brand-name cardiac medication used in the treatment of transthyretin cardiac amyloidosis. The delivery order demonstrates AmerisourceBergen's continued role as a critical federal medical vendor, supplying specialized pharmaceutical products to support military and veteran healthcare systems. As a major pharmaceutical distributor serving the Defense Logistics Agency's Medical Supply Chain, the company maintains the capability to deliver a comprehensive range of pharmaceutical products across multiple therapeutic domains, from specialty medications to generic drugs, vaccines, and medical supplies required by military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FDD2J?
SPE2DR26FDD2J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 3, 2026.
How much is contract SPE2DR26FDD2J worth?
The government has obligated $14,593 on SPE2DR26FDD2J.
Is contract SPE2DR26FDD2J an order under another contract?
Yes. SPE2DR26FDD2J is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FDD2J competed?
The extent of competition for SPE2DR26FDD2J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award